NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.58%
After-hours: Aug 15, 2025, 07:55 PM EDT

NLS Pharmaceutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-73.77 -61.57 -54.82
PEG Ratio
1.19 -16.62 -1.47
PS Ratio
n/a n/a n/a
PB Ratio
-101.65 309.56 1.21K
P/FCF Ratio
-92.72 -73.18 -43.73
P/OCF Ratio
-92.72 -73.18 -43.84
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
-0.18 n/a n/a
Quick Ratio
0.23 2.76 2.40
Current Ratio
0.23 2.75 2.38
Asset Turnover
n/a n/a n/a
Interest Coverage
-81.34 -153.49 -174.08
Return on Equity
1.38 -5.03 -22.02
Return on Assets
-6.59 -1.78 -2.07
Return on Invested Capital
2.66 -2.62 -3.53
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a